Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.47%
1,067.36
+4.96
+0.47%
1,062.401,064.141,071.991,061.02
SIXC
Communications
SIXC
Communications
SIXC
-0.54%
603.48
-3.26
-0.54%
606.74606.74609.84602.33
SIXE
Energy
SIXE
Energy
SIXE
+0.54%
1,244.93
+6.72
+0.54%
1,238.211,236.601,247.741,232.10
SIXI
Industrials
SIXI
Industrials
SIXI
+0.68%
1,730.38
+11.77
+0.68%
1,718.611,723.231,741.481,717.47
SIXM
Financials
SIXM
Financials
SIXM
+0.33%
639.47
+2.10
+0.33%
637.37638.27642.30638.27
SIXR
Staples
SIXR
Staples
SIXR
+0.16%
854.95
+1.36
+0.16%
853.59854.05858.19851.34
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.11%
218.56
+0.23
+0.11%
218.33218.33219.73217.15
SIXT
Technology
SIXT
Technology
SIXT
+1.02%
3,631.59
+36.78
+1.02%
3,594.813,620.103,657.473,615.34
SIXU
Utilities
SIXU
Utilities
SIXU
+0.80%
915.77
+7.23
+0.80%
908.54909.50917.35907.07
SIXV
Health care
SIXV
Health care
SIXV
+1.19%
1,512.81
+17.81
+1.19%
1,495.001,499.611,517.101,499.61
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.41%
2,408.21
+9.90
+0.41%
2,398.312,406.822,421.802,404.22
APS:TSE
Aptose Biosciences Inc
CA$2.38
+2.15%
(+0.050) 1D
May 22, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for APS...
Open
CA$2.33
High
CA$2.38
Low
CA$2.33
Mkt. cap
39.15M
Avg. vol.
2.58K
Volume
3.12K
52-wk high
CA$2.59
52-wk low
CA$1.02
Beta
0.08
Shares outstanding
2.55M
No. of employees
14
News stories
From sources across the web
About Aptose Biosciences Inc
CEO-
Employees14
Founded1986
HeadquartersToronto, Ontario, Canada
SectorBiotechnology
Websiteaptose.com
Last report
Aug 13, 2025
Fiscal period
Q2 2025
EPS / Est. (USD)
-$2.76 / -$2.74
-0.73%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q2 2025 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.30M
2.20M
3.47M
3.62M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.62M
2.71M
3.95M
3.56M
Operating expense
6.92M
4.91M
7.43M
7.18M
Total operating expenses
6.92M
4.91M
7.43M
7.18M
Operating income
-6.92M
-4.91M
-7.43M
-7.18M
Other non operating income
-
-
-
-19.00K
EBT including unusual items
-7.04M
-5.12M
-7.76M
-7.63M
EBT excluding unusual items
-7.04M
-5.12M
-7.76M
-7.63M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-7.04M
-5.12M
-7.76M
-7.63M
Net profit margin
-
-
-
-
Earnings per share
-2.76
-
-
-
Interest and investment income
-
-
105.00K
-
Interest expense
-110.00K
-212.00K
-437.00K
-433.00K
Net interest expenses
-110.00K
-212.00K
-332.00K
-433.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-6.92M
-4.90M
-7.42M
-7.18M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more